|
2020
|
Invention
|
Dihydroimidazo pyrimido pyrimidinone compound. A dihydroimidazo pyrimido pyrimidinone compound of... |
|
|
Invention
|
Substituted imidazoquinoxaline compounds and uses thereof. 13122 are defined herein. The compound... |
|
|
Invention
|
3, 5-disubstituted pyrazole compounds as kinase inhibitors and uses thereof. 02066, L, Z and Q ar... |
|
|
Invention
|
Substituted pyrazoloquinazolone compound and application thereof. A compound of formula I, or a s... |
|
|
Invention
|
Substituted fused heteroaromatic bicyclic compounds as kinase inhibitors and the use thereof. 161... |
|
2019
|
Invention
|
1-(arylmethyl)quinazoline-2,4(1h,3h)-diones as parp inhibitors and the use thereof. Disclosed are... |
|
2018
|
Invention
|
Imidazo[1,2-b]pyrimido[4,5-d]pyridazin-5(6h)-one compound and use thereof. 155 are as defined her... |
|
|
Invention
|
Substituted fused heteroaryl tricyclic compound as kinase inhibitor and application thereof. Prov... |
|
|
Invention
|
Substituted fused heteroaromatic compounds as kinase inhibitors and the use thereof. The disclosu... |
|
|
Invention
|
Substituted fused heteroaryl compound serving as a kinase inhibitor, and applications thereof. Th... |
|
2017
|
Invention
|
8,9-dihydroimidazo[1,2-a]pyrimido[5,4-e]pyrimidin-5(6h)-ones. Disclosed are 8,9-dihydroimidazo[1,... |
|
|
Invention
|
8,9-dihydroimidazole[1,2-a]pyrimido[5,4-e]pyrimidine-5(6h)-ketone compound. Provided is a 8,9-dih... |
|
|
Invention
|
Application of hedgehog pathway inhibitor in treating fibrosis diseases.
This disclosure relates... |
|
|
Invention
|
Application of hedgehog pathway inhibitor for treatment of fibrotic diseases. The present inventi... |
|
|
Invention
|
Process for the preparation of 1-(arylmethyl)quinazoline-2,4(1h,3h)-diones. This disclosure provi... |
|
|
Invention
|
Manufacturing process for 1-(arylmethyl) quinazoline-2,4 (1h, 3h)-dione. Provided in the present ... |
|
2016
|
Invention
|
Solid pharmaceutical formulation of parp inhibitors and use thereof. The present invention provid... |
|
|
Invention
|
Solid pharmaceutical dosage form of parp inhibitor, and application of solid pharmaceutical dosag... |
|
2013
|
Invention
|
N-(3-heteroarylaryl)-4-arylarylcarboxamides and analogs as hedgehog pathway inhibitors and use th... |
|
|
Invention
|
N-(3-heteroarylaryl)-4-arylarylcarboxamtdes and analogs as hedgehog pathway inhibitors and use th... |
|
2012
|
Invention
|
1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof. Disclose... |
|
|
Invention
|
4-(3-heteroarylarylamino)quinazoline and 1-(3-heteroarylarylamino)isoquinoline as hedgehog pathwa... |
|
|
Invention
|
6-(aryl-carboxamide) imidazo [1,2-a] pyrimidine and 6-(aryl carboxamide) [1,2,4] triazolo [4,3-a]... |
|
|
Invention
|
H)-diones as parp inhibitors and the use thereof. 6 are defined herein. Compounds having Formula ... |
|
|
Invention
|
Quinazolinediones and their use. The present invention discloses compounds of formula (I), or pha... |
|
|
Invention
|
3-aryl-6-aryl-[1,2,4]triazolo[4,3-b]pyridazine as cell proliferation inhibiting agent and use the... |
|
2011
|
Invention
|
3-aryl-6-aryl-[1,2,4]triazolo[4,3-α]pyridines as inhibitors of cell proliferation and the use the... |
|
2010
|
Invention
|
3-aryl-6-aryl-[1,2,4]triazolo[4,3-a]pyridines as inhibitors of cell proliferation and the use the... |
